Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Pulmonary Chronic GVHD
NCT01163786Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Oct 2010
- Primary completion
- Sep 2015
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in Bronchiolitis Obliterans (BO), sponsored by Northwestern University. Started Oct 2010; status: terminated.
02
Drugs
bortezomib
03
Conditions
Bronchiolitis Obliterans (BO)
Beyond the preview
Go deeper on NCT01163786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01163786.